Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
This review illustrates the recent understanding of amyloid-β oligomers' characteristics and toxicity-related pathways, along with inhibitors against Aβ aggregation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ plaques are accumulations of sticky Aβ peptides outside of the neurons and impede the synaptic communication between neurons, leading to neuronal death.”
From Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease (2025) · cites this paper as [3]
In the citing paper
“Aβ peptides are formed by proteolytic cleavage of the amyloid precursor protein (APP), specifically the hydrophobic transmembrane portion, by β- and γ-secretases [3].”
From Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease (2025) · cites this paper as [3]
In the citing paper
“Soluble Aβ oligomers are the primary neurotoxic substances,131–133”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [133]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Cohen, S. I. A., Linse, S., Luheshi, L. M., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218402110 · Cited by 1,440
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., & Wanker, E. E. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1437 · Cited by 1,434
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Cited by
Items 501–577 of 577
Na, C., Kim, G., Bal, W., Nam, E., & Lim, M. H. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-061jk
Self-citationGao, W., Gao, B., Wang, S., Wu, D., Mei, P., Geng, L., Li, C., Li, Y., Liu, X., Pan, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.28.656730 · Cited by 1
The Link Between Diabetes, Glucose Control, and Alzheimer's Disease and Neurodegenerative Diseases
Verdile, G., Fraser, P. E., & Martins, R. N. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch4
Molecular mechanisms of fibrillation of IDPs
Salvi, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816348-1.00008-9
Feng, L. (2019) · Research Online (University of Wollongong)
The Metabolic Relationship between Type 2 Diabetes and Alzheimer's Disease
Ayala, D. (2019) · UA Campus Repository (The University of Arizona)
Perphenazine-macrocycle conjugates rapidly sequester the Aβ42 monomer and inhibit amyloid formationPreprint
Ball, S. R., Adamson, J. S. P., Sullivan, M. A., Zimmermann, M. R., Lo, V., Sanz-Hernández, M., Jiang, F. N., Kwan, A. H., Werry, E. L., Knowles, T. P. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.16.384248
Han, J., Nam, E., Yoon, J., Qian, T., Li, Y., Lee, S., & Lim, M. H. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14736882.v1
Self-citationNam, G., Yi, Y., Lee, H. J., Lee, J., Kang, J., & Lim, M. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.14902-9
Self-citationAlzheimer’s disease as a syndrome of overloaded amyloidic synaptic tagging in memory networksPreprint
Murphy, N. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/7gsaz
APP-C31 Is an Intracellular Promoter of Amyloid-Beta Aggregation and ToxicityPreprint
Nam, E., Park, J., Lin, Y., Do, H., Han, J., Lee, Y. H., Baik, M., & Lim, M. H. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14610261
Self-citationHan, J., Nam, E., Yoon, J., Qian, T., Li, Y., Lee, S., & Lim, M. H. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14736882
Self-citationAmplification of Amyloid Protein-induced Aggregation of the Eukaryotic Ribosome
Ferdosh, S., Banerjee, S., & Barat, C. (2022) · Protein and Peptide Letters · doi:10.2174/0929866529666220905112156
Liu, C., Wu, J., Hu, C., Yang, A., Shen, R., & Kou, X. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4199898
Therapeutics of Extracellular Vesicles in Cardiocerebrovascular and Metabolic Diseases
Hou, Z., Lin, Y., Yang, X., Chen, J., & Li, G. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1443-2_13
Fractal nature of benzene stacking interactions
Jovanovic, N. M., Etinski, M., & Stanković, I. M. (2023) · Journal of Molecular Modeling · doi:10.1007/s00894-023-05689-z
Novel therapies for the treatment of Alzheimer's disease
Zhang, R. (2023) · International Conference on Modern Medicine and Global Health (ICMMGH) · doi:10.1117/12.2692195
Sahraei, A., Shamsoddini, M. J., Mohammadi, F., & Hassani, L. (2023) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2023.149307
Lakela, A. L., Berntsson, E., Vosough, F., Jarvet, J., Paul, S., Barth, A., Gräslund, A., Roos, P. M., & Wärmländer, S. K. T. S. (2023) · Research Square · doi:10.21203/rs.3.rs-3697127/v1
Zhang, L., Cao, K., Xie, J., Liang, X., Luo, Q., & Luo, H. (2023) · Research Square · doi:10.21203/rs.3.rs-3715133/v1
The nature of tyrosine-aminated amyloid-βPreprint
Gao, Z., Hu, T., Wu, J., Fu, S., & Li, H. (2024) · Research Square · doi:10.21203/rs.3.rs-3752850/v1
Molecular mechanism of Alzheimer’s β-amyloid peptide aggregation
Li, Y., Mao, X., Liu, K., & Niu, Z. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-1167
Gao, Z., Hu, T., Wu, J., Fu, S., & Li, H. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4954663
Exploring the Connection Between Nanomaterials and Neurodegenerative Disorders
Nanda, S. S., & Yi, D. K. (2024) · Micromachines · doi:10.3390/mi15111382
An approach to predict and inhibit Amyloid Beta dimerization pattern in Alzheimer’s disease
Roy, S., Biswas, S., Nandy, A., Guha, D., Dasgupta, R., Bagchi, A., & Sil, P. C. (2024) · Toxicology Reports · doi:10.1016/j.toxrep.2024.101879
“[27]; but in the contrary the A β monomer ’ s structure is distributed be-tween some random coil and helix as depicted by the prepared WT monomer model in Fig.”
Zhou, Y. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2024.19863
Berntsson, E., Noormägi, A., Padari, K., Jarvet, J., Gräslund, A., Palumaa, P., & Wärmländer, S. K. T. S. (2025) · Research Square · doi:10.21203/rs.3.rs-5888115/v1
Impact of tyrosine amination on the aggregation and neurotoxicity of amyloid-β
Hu, T., Wu, J., Fu, S., Li, H., & Gao, Z. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141700
Nojiri, K., Hatakawa, Y., Lee, S. H., & Oe, T. (2025) · Analytical Sciences · doi:10.1007/s44211-025-00795-9
“Recently, the Aβ oligomer (the precursor to β-sheet fibril formation) has been recognized as a more toxic species than the Aβ fibril in Alzheimer’s disease [25, 26].”
Self-citationSharma, H., Sharma, N., & An, S. S. A. (2025) · PubMed Central · doi:10.3390/molecules30153138
“Amyloid fibrils are known to interact with cellular receptors, disrupt signal transduction pathways, increase reactive oxygen species (ROS), trigger inflammation, activate the immune system, and ultimately cause cell death [32].”
Isotopic Dilution Provides No Evidence for Cu2+-Bridged β-Amyloid Homo-Oligomers
Drew, S. C. (2025) · Applied Magnetic Resonance · doi:10.1007/s00723-025-01795-8
Nutraceuticals intervention in Alzheimer's disease: From farm to pharma
Chaithra, P. M., Rakshith, B. S., Logesh, S., Basalingappa, K. M., Gopenath, T. S., Chang, H., Perry, G. L., & Singh, S. K. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251385216 · Cited by 1
“14,15 Mutations in the APP , presenilin-1 ( PSEN1 ), and presenilin-2 ( PSEN2 ) genes are found to be responsible for A β PP cleavage, leading to high cerebral A β levels, contributing to its accumulation and deposition in the brain.”
Neural Stem Cell-conditioned Medium Protected Against Cognitive Dysfunction in APP/PS1 Mice
Zheng, X., Xiang, Q., Dong, X., Shen, Y., Qu, T., Fang, W., & Yang, H. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05282-w · Cited by 2
Bigi, A., Napolitano, L., Vadukul, D. M., Chiti, F., Cecchi, C., Aprile, F. A., & Cascella, R. (2024) · Figshare · doi:10.6084/m9.figshare.25025878
Zhang, L., Cao, K., Xie, J., Liang, X., Gong, H., Luo, Z., & Luo, H. (2024) · Figshare · doi:10.6084/m9.figshare.25893785
Chen, J., Tang, X., Hu, Y., Feng, H., Zhang, G., Zhang, D., Huang, Y., & Zhao, R. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c07117
A sulfur-atom-enhanced strategy for NIR imaging of soluble and insoluble amyloid-β species
Zhao, X., Zhu, Z., Wang, Y., Sun, M., Li, N., Su, Z. Q., & Huang, W. (2026) · Talanta · doi:10.1016/j.talanta.2026.129417
Zinc sequestering dual-functional molecules for bimodal targeting inhibition of Aβ42-aggregation
Yan, S., liu, P., Si, Y., Wu, H., Quan, J., Wang, L., & Akkaya, E. U. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109629
Sanagi, T., Okumura, M., Lin, Y., Kanemura, S., Moon, E., Heo, Y., Takahara, K., Lee, Y.-H., & Tsunematsu, T. (2026) · Biophysical Chemistry · doi:10.1016/j.bpc.2026.107599
Toublet, F. (2019) · theses.fr (ABES) · doi:10.70675/ce2e69d8zf6fez40cdz9605z8b0883cefb6a · Cited by 2
Development of copper ligands for therepeutic applications
Balderrama-Martínez-Sotomayor, R. (2020) · theses.fr (ABES) · doi:10.70675/449f1d52z9b40z487cza9cczb4edaf3b75f1
Freyssin, A. (2020) · theses.fr (ABES) · doi:10.70675/0db2e37dz547bz4731z852dz9b843c062cba
Célestine, M. (2023) · theses.fr (ABES) · doi:10.70675/873ca377z9a97z43f6z8051zdab4082686ba · Cited by 1
The role of the α7 nicotinic acetylcholine receptor in a model of amyloid pathology
Santos, D. G. (2024) · theses.fr (ABES) · doi:10.70675/b3ed4de5zcd9ez4421za129z0a05130d86b9
Allouche, A., Colin, J., Birck, C., Schroeder, H., Tallandier, V., Baldoni, M., Muller, C., Afrassi, M., & Violle, N. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02051-2 · Cited by 1
“However, due to their polymorphic, transient, and heterogeneous nature, AβOs remain technically challenging to isolate, stabilize, and characterize [9, 11].”
Mai, X., Chen, J., Yong, K., Chen, Y., Wen, H., Sun, M., Yu, H., Xiong, K., & Yu, L. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c08075
Barros, T. G. R., Grossi, L. B., Campos, M. L. D. S., Cardoso, I. B.-H. N., Teixeira, A. L., de Miranda, A. S., & Toscano, E. C. D. B. (2026) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.70077
Gong, H., Li, Z., Zhao, Y., Wang, Z., & Luo, W. (2026) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2026.128160
Kwak, J., 박성민, Kim, Y., Hwang, Y., Lee, S. J., Kim, J. G., & Lim, M. H. (2026) · Chemical Science · doi:10.1039/d6sc03446b
Self-citationLiu, W. T., Chen, Y., Ren, H., Tian, L., Zhang, Y. Z., Miao, S., & Yang, P. (2026) · JACS Au · doi:10.1021/jacsau.6c00510
Siddiqui, F., Khanam, S., Faruqui, T., Mishra, P., Mahmood, S., Mir, S. S., & Khan, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05955-0
“Second, AuNPs remodel oligomeric intermediates by destabilizing on-pathway aggregates and redirecting aggregation toward less toxic, soluble conformations [82].”
Pan, T., Fang, J., Wang, X., Chen, Y., Li, S., Qiu, G., (401658), C. S., Liu, C., Li, A., & Chen, F. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02354-3
“While Aβ oligomers are highly neurotoxic and potent initiators of plaque formation, early AD involves a broader spectrum of pathological factors, including Aβ monomers, other amyloid precursor protein fragments, and tau pathology [14, 17].”
Venkei, Z. G., & Savelieff, M. G. (2026) · Exploration of neuroscience · doi:10.37349/en.2026.1006139
Self-citationSmall Molecules as Anti-Alzheimer’s Scaffolds
Hazra, R., Roy, S., Gayen, S., Parui, A., Arshad, A., Roy, N., & Sarkar, A. N. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815646126010013
Ke, Q., Xiong, Y., Cai, Z., Chen, F., Zhou, Z., Chen, Z., Huang, Y., Fang, S., Wu, P., Wang, S., et al. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.1351374
Ke, Q., Xiong, Y., Cai, Z., Chen, F., Zhou, Z., Chen, Z., Huang, Y., Fang, S., Wu, P., Wang, S., et al. (2026) · Angewandte Chemie · doi:10.1002/ange.1351374
Metal–organic macrocycles as molecular modulators of amyloid-β aggregation and cytotoxicity
Na, C., Gupta, G., Kim, M., Choe, Y., Lee, J., Lee, C. Y., & Lim, M. H. (2026) · Chemical Science · doi:10.1039/d6sc04289a
Self-citationLiao, Y.-F., Chang, H., Hsu, W., Chen, P.-J., Hsieh, C., Huang, S., Wu, M., Tu, L., Lee, M., Tai, H., et al. (2026) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.70264
Targeting soluble misfolded oligomers in anti-amyloid research
Vosbein, P., Mao, H., & Lou, C. (2026) · Nature Reviews Chemistry · doi:10.1038/s41570-026-00867-y
“Unlike solid plaques, small AβOs are diffusible and can interact with neuronal membranes and receptors, leading to synaptic dysfunction 3,214 .”
Malafaia, D., Melo, L., Silva, A. M. S., & Albuquerque, H. M. T. (2026) · ChemMedChem · doi:10.1002/cmdc.70453
de Campos, R. M., Carraro, M. F., Bitencourt, A. L. B., Jerisha, J., Ayon, N. J., Juska, V. B., Pinheiro, N. R., Johnson, E. A., Nowar, R., McGee, J. P., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113499
“Unlike fibrillar deposits, A β Os are metastable and structurally heterogeneous, making them difficult to isolate and characterize (7).”
Avendaño-Godoy, J., Álamos, C., Araya, E., Olea‐Azar, C., Ortega-Campos, J., Cattoën, X., Valenzuela, J. M., & Kogan, M. J. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.215149
Rationally Designed Peptides and Peptoids as Inhibitors of Amyloid-β (Aβ) Aggregation
Huang, X., Ma, S., Li, X., & Pan, J. (2026) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6c00145
Milardi, D., Han, J., Lee, H. J., Ding, F., Miller, Y., Faller, P., Bush, A. I., Crouch, P. J., Finkelstein, D. I., Double, K. L., et al. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00420
Self-citationTemporally Decoupled Ring-Opening Polymerization of N -Carboxyanhydrides-Induced Self-Assembly
Gu, Q., Liu, S., Cornel, E. J., Jiang, J., & Du, J. (2026) · Macromolecules · doi:10.1021/acs.macromol.6c01803
Hong, E., 박성민, Lin, Y., Kwak, J., Lee, Y.-H., & Lim, M. H. (2026) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2026.103563
Self-citationPark, S., Hwang, Y., Kwak, J., Lin, Y., Park, H., Nam, E., Han, J., Park, S. C., Kim, H., Kim, J., et al. (2026) · Advanced Science · doi:10.1002/advs.77886
“In contrast, redirecting A β amyloidogenesis away from canonical fibrillation can yield non-fibrillar, unstructured aggregates (Figure 1a ) that are less toxic, providing a conceptual basis for next-generation biomaterials designed to reprogram pathological biomolecular assembly [ 28, 29 ].”
Self-citationLa, J. A., Ko, H., 최인희, & Kang, T. (2026) · BioChip Journal · doi:10.1007/s13206-026-00281-y
“Oligomer formation is an early event in Aβ assembly [3], and time-resolved measurements have shown that non-fibrillar Aβ oligomers can develop within the first 10 min under aggregation-promoting in vitro conditions [5].”
InfluentialBindingDB (2026) · UC San Diego · doi:10.7270/q2wm1kc7
Metadata
- Authors
- Lee, S. J. C., Nam, E., Lee, H. J., Savelieff, M. G., & Lim, M. H.
- Affiliations
- Ulsan National Institute of Science and Technology (KR)
- University of Michigan (US)
- Corresponding author
- Lim, Mi Hee
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2017
- Volume
- 46
- Issue
- 2
- Pages
- 310-323
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2550762885
- Cited by
- 576
- References
- 51
- Citations by year
- 2026: 38 · 2025: 69 · 2024: 72 · 2023: 75 · 2022: 66 · 2021: 78 · 2020: 60 · 2019: 54 · 2018: 45 · 2017: 18
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Society Reviews (publishedVersion)
- PubMed (publishedVersion)
- Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta oligomers, Alzheimer's disease, amyloid-beta aggregation, amyloid fibril formation, amyloidosis, amyloid-beta clearance
- MeSH terms
- Alzheimer Disease, Humans, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.